Cancer protection.
D000091162:AMP-Activated Protein Kinase Kinases; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy; D004789:Enzyme Activation; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008687:Metformin / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000201:enzymology / Q000209:etiology / Q000517:prevention & control*; D011494:Protein Kinases / Q000378:metabolism
D007004:Hypoglycemic Agents; D008687:Metformin; D011494:Protein Kinases; D000091162:AMP-Activated Protein Kinase Kinases